[ad_1]
These trying to slim down earlier than the New Year may need to heed an vital warning.
On Thursday, the FDA said that it had seized “1000’s of models” of counterfeit Ozempic, a semaglutide injectable used as a weight reduction drug, which have made their option to pharmacies and suppliers.
The company says that 5 individuals have been affected by the counterfeit medication to this point however that their circumstances haven’t been critical, and their signs are “in keeping with recognized widespread antagonistic reactions” to genuine Ozempic, together with nausea, vomiting and diarrhea.
Associated: A New Weight-Loss Drug Could Be a Complete Game Changer. ‘Psychologically, You Don’t Want to Eat.’
The FDA warned that not solely is the Ozempic substance itself counterfeit, however the drug data, label, carton and needle used for the injection are additionally counterfeit, noting that there is no option to verify that the needles are sterile.
Sufferers and pharmacies are inspired to buy the substance solely via distributors approved by Novo Nordisk, Ozempic’s producer.
“FDA takes reviews of attainable counterfeit merchandise significantly and works intently with different federal companies and the non-public sector to assist shield the nation’s drug provide,” the company wrote in a release. “FDA’s investigation is ongoing, and the company is working with Novo Nordisk to determine, examine, and take away additional suspected counterfeit semaglutide injectable merchandise discovered within the U.S.”
In June, Novo Nordisk filed lawsuits in opposition to 5 med spas and wellness clinics in 4 U.S. states for allegedly promoting counterfeit Ozempic and Wegovy, one other weight reduction drug.
Associated: Novo Nordisk, the Maker of Ozempic, Is Suing Spas and Clinics For Allegedly Selling Knockoffs
“Our precedence is to make sure that sufferers have a protected and optimistic expertise with our FDA-approved semaglutide medicines, and these actions are a direct reflection of that focus,” Doug Langa, president of Novo Nordisk, stated in a company release on the time. “We imagine it is vital to offer further instruments and schooling to help the right use of our authorized semaglutide merchandise and create broad public consciousness concerning the distinction between our FDA-approved medicines and different merchandise being labeled as semaglutide.”
Those that imagine they could have been offered counterfeit remedy are inspired to report it to the FDA here.
[ad_2]
Source link
